SCHEMBL19976763

SCHEMBL19976763

CCOCCN/C(=N/C(=O)c1ccc(Cl)cc1)Nc1n[nH]c2cc(C(F)(F)F)ccc12

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.52
TRPA1 O75762 2/20 0.47
HDAC6 Q9UBN7 6/20 0.44
MAPK1 P28482 2/20 0.41
MAP2K4 P45985 1/20 0.41
MAPK6 Q16659 1/20 0.41
MAPKAPK5 Q8IW41 1/20 0.41
KIT P10721 2/20 0.40
FLT3 P36888 1/20 0.39
ITK Q08881 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNQ1 P51787 1/20 0.38
SCN5A Q14524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976812 0.91 GSK3B (0.51) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976817 0.90 GSK3B (0.53) GSK3BHDAC6MAPK1MAP2K4HDAC1
SCHEMBL19976907 0.90 GSK3B (0.49) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976882 0.89 MAPK1 (0.46) GSK3BHDAC6MAPK1MAP2K4MAPK6
SCHEMBL19976828 0.87 GSK3B (0.49) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976753 0.87 GSK3B (0.47) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976815 0.85 GSK3B (0.44) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976764 0.85 GSK3B (0.48) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976733 0.82 HDAC6 (0.47) GSK3BTRPA1HDAC6MAPK1MAP2K4
SCHEMBL19976858 0.80 MAPK1 (0.46) GSK3BHDAC6MAPK1MAP2K4MAPK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed